Drawing for FLOW TWIN

USPTO serial 79435758

FLOW TWIN

Reviewed by CopyMark Law Group

Status 645Office Action
Filing date
Status date
Registration date
—
Examiner
KRUSSMAN, IAN GEORGE
Law office
TMO LAW OFFICE 126

What this means

The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.

Status 645: Status 645 means the USPTO mailed a final refusal maintaining at least one objection to your application. You can respond, appeal to the Trademark Trial and Appeal Board, or allow the application to abandon.

Need help with FLOW TWIN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Office Action, set up monitoring, or talk with CopyMark.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Burton S. Ehrlich

Burton S. Ehrlich Ladas & Parry LLP224 S. Michigan AvenueSuite 1600Chicago, IL 60604

Goods and services

ClassDescriptionStatusFirst use
009Simulators for medical training in the field of human and animal anatomy, namely, computers, downloadable or recorded software for vascular anatomy visualization, endovascular treatment simulation and medical procedure planning, computer monitors and their structural components for medical research, treatment planning, teaching and education; downloadable or recorded medical application software for vascular anatomy visualization, endovascular procedure simulation and medical procedure planning; 3D physical medical teaching models and downloadable or recorded software for virtually representing parts of the human and animal body; apparatus and devices for simulating a medical treatment of the human and animal bodyACTIVE—
010Surgical and medical apparatus and instruments for endovascular procedures, neurovascular interventions, and pre-therapeutic planning; radiological diagnostic imaging apparatus for medical use; X-ray based diagnostic apparatus for medical use; apparatus for medical analysis of vascular anatomy and blood flow hemodynamics; apparatus and devices for medical use for planning medical treatments, namely, patient-specific 3D vascular models and vascular simulators; apparatus and devices for medical use for simulating medical treatment of the human and animal body, namely , patient-specific vascular models; apparatus and devices for medical use for obtaining a virtual and material representation of a part of the human and animal bodyACTIVE—
041Providing medical educational classes, seminars, workshops and hands-on training sessions; teaching and training; conducting of medical and biomedical training seminars; training concerning the use of surgical and medical apparatus and instruments; arranging, conducting and organization of seminars, lectures and symposiums for medical and surgical training purposes; rental of medical simulators for teaching and training purposes; online provision of virtual representations of the human anatomy for teaching and training purposes; rental of medical diagnostic simulators for use with medical teaching simulation models and teaching aidsACTIVE—
042Design and development of software for medical procedure practicing, medical training and development of medical devices; design and development of patient-specific 3D vascular models and computer tools for endovascular procedure simulation; design and development of computer hardware and software for use in the medical field; providing information with respect to medical research; rental of laboratory and measuring instruments; Software as a Service (SaaS) services featuring software for simulating human and animal vascular anatomy; design of computer hardware and software; consulting services with respect to medical simulation tool and model developmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 28, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Sep 28, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 28, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 19, 2026RFNTREFUSAL PROCESSED BY IB—
Mar 5, 2026RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 4, 2026RFRRREFUSAL PROCESSED BY MPU—
Feb 4, 2026RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 3, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 31, 2026DOCKASSIGNED TO EXAMINER—
Jan 30, 2026MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 30, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 17, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Oct 30, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance